127 Dongming Road, Zhengzhou, Henan, 450000, China
Henan Cancer Hospital ,Affiliated Cancer Hospital of Zhengzhou University, China (People's Republic)
Dr Keshu Zhou is the Chief Physician and PhD Supervisor at Zhengzhou University. She is also the Deputy Director of the Hematology Department at Henan Cancer Hospital, serves as the Outstanding Contribution Expert in the field of lymphoma in china. She specializes in the diagnosis and treatment of lymphatic system tumors, making significant contributions to the standardized diagnosis and personalized treatment of lymphatic system tumors, clinical research of new lymphoma drugs, and cell therapy for hematologic tumors.
As a Principal Investigator (PI), she has led over 100 international and domestic multicenter clinical trials for new lymphoma drugs, undergoing numerous pre-marketing inspections, including those by the FDA. She successfully facilitated the market approval of new anti-lymphoma drugs such as Zanubrutinib, notably advancing it to become the first locally developed anti-cancer drug approved for the U.S. market after FDA inspection, breaking new ground. She has made significant contributions to the global expansion of Zanubrutinib's indications. Some clinical trial results were presented as oral reports at the 2023 Lugano Lymphoma Conference in Switzerland and the American Society of Hematology Annual Meeting.
As a renowned expert in the field of lymphoma, she has participated in the formulation of several domestic lymphoma guidelines and expert consensus, making important contributions to the promotion of standardized diagnosis and treatment of lymphoma.